Evolent Health Operating Income Over Time
| EVH Stock | USD 3.25 0.07 2.11% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Evolent Health Performance and Evolent Health Correlation. Is there potential for Health Care Technology market expansion? Will Evolent introduce new products? Factors like these will boost the valuation of Evolent Health. Projected growth potential of Evolent fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.57) | Revenue Per Share | Quarterly Revenue Growth (0.28) | Return On Assets | Return On Equity |
Understanding Evolent Health requires distinguishing between market price and book value, where the latter reflects Evolent's accounting equity. The concept of intrinsic value - what Evolent Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Evolent Health's price substantially above or below its fundamental value.
It's important to distinguish between Evolent Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Evolent Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Evolent Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Income Analysis
Compare Evolent Health and related stocks such as Nutex Health, HealthStream, and AMN Healthcare Services Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NUTX | (684 K) | (844.6 K) | (533 K) | (533 K) | (533 K) | (533 K) | (448.6 K) | (5.7 M) | (1.8 M) | 34.7 M | 153.2 M | 170.3 M | (406.6 M) | (31.8 M) | 130.6 M | 117.6 M | 123.4 M |
| HSTM | (4.6 M) | 11.3 M | 13.5 M | 14.7 M | 16.4 M | 13.6 M | 5.6 M | 9.8 M | 15.5 M | 14.7 M | 15.8 M | 8.1 M | 12.4 M | 16 M | 21.3 M | 20.2 M | 21.2 M |
| AMN | 2.2 M | 37.6 M | 53.3 M | 65.5 M | 67.9 M | 128.9 M | 191.6 M | 212.4 M | 202.8 M | 176.9 M | 149.3 M | 478 M | 647.1 M | 338.4 M | (102.7 M) | 33.2 M | 31.5 M |
| MYGN | (8.9 M) | 157.8 M | 180.3 M | 228 M | 274.4 M | 134.2 M | 166.8 M | 49.4 M | 118.7 M | 7.6 M | (194.8 M) | (190.5 M) | (140.6 M) | (257.4 M) | (123.5 M) | (139.3 M) | (132.3 M) |
| REPL | (9.6 M) | (9.6 M) | (9.6 M) | (9.6 M) | (9.6 M) | (9.6 M) | (9.6 M) | (19.2 M) | (30.9 M) | (56.2 M) | (82.8 M) | (121.5 M) | (177.1 M) | (234.8 M) | (261.6 M) | (235.5 M) | (223.7 M) |
| AVBP | (8.7 M) | (8.7 M) | (8.7 M) | (8.7 M) | (8.7 M) | (8.7 M) | (8.7 M) | (8.7 M) | (8.7 M) | (8.7 M) | (8.7 M) | (36.9 M) | (74.6 M) | (94.3 M) | (94.3 M) | (84.9 M) | (89.1 M) |
| MGTX | (20.1 M) | (20.1 M) | (20.1 M) | (20.1 M) | (20.1 M) | (20.1 M) | (20.1 M) | (31.7 M) | (78.1 M) | (58.3 M) | (62.6 M) | (72.8 M) | (116.4 M) | (137.1 M) | (164.2 M) | (147.8 M) | (140.4 M) |
| BFLY | (53.1 M) | (53.1 M) | (53.1 M) | (53.1 M) | (53.1 M) | (53.1 M) | (53.1 M) | (53.1 M) | (53.1 M) | (102.3 M) | (161.6 M) | (192.7 M) | (193 M) | (145.6 M) | (74.4 M) | (86.4 M) | (90.7 M) |
| PSNL | (22.2 M) | (22.2 M) | (22.2 M) | (22.2 M) | (22.2 M) | (22.2 M) | (22.2 M) | (22.2 M) | (13.8 M) | (22.4 M) | (42.1 M) | (65.4 M) | (115.5 M) | (109.9 M) | (68.3 M) | (88.1 M) | (92.5 M) |
| KURA | (33.6 K) | (20.5 K) | (23.4 K) | (22.3 K) | (11.8 M) | (23.9 M) | (28.4 M) | (36.1 M) | (62.9 M) | (67.5 M) | (91.9 M) | (131.3 M) | (139.9 M) | (165.8 M) | (193.2 M) | (173.9 M) | (165.2 M) |
Evolent Health and related stocks such as Nutex Health, HealthStream, and AMN Healthcare Services Operating Income description
Operating Income is the amount of profit realized from Evolent Health operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Evolent Health is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Evolent Health | EVH |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 1812 N Moore |
| Exchange | New York Stock Exchange |
USD 3.25
Check out Evolent Health Performance and Evolent Health Correlation. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Evolent Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.